MX2021002572A - Parches transdermicos para uso en auriculoterapia. - Google Patents

Parches transdermicos para uso en auriculoterapia.

Info

Publication number
MX2021002572A
MX2021002572A MX2021002572A MX2021002572A MX2021002572A MX 2021002572 A MX2021002572 A MX 2021002572A MX 2021002572 A MX2021002572 A MX 2021002572A MX 2021002572 A MX2021002572 A MX 2021002572A MX 2021002572 A MX2021002572 A MX 2021002572A
Authority
MX
Mexico
Prior art keywords
auriculotherapy
transdermal patches
neurotransmitters
caffeine
chocolate
Prior art date
Application number
MX2021002572A
Other languages
English (en)
Inventor
Zancas Maria Luisa Nuñez
Ribo Blanca Cortadellas
Original Assignee
Qm Health Care & Nutrition S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qm Health Care & Nutrition S L filed Critical Qm Health Care & Nutrition S L
Publication of MX2021002572A publication Critical patent/MX2021002572A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Parche transdérmico para uso en auriculoterapia que comprende al menos un principio activo seleccionado entre cafeína, chocolate y glutamina para la modulación de neurotransmisores.
MX2021002572A 2018-10-25 2019-10-22 Parches transdermicos para uso en auriculoterapia. MX2021002572A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18382756.7A EP3643296A1 (en) 2018-10-25 2018-10-25 Transdermal patches for use in auriculotherapy
PCT/ES2019/070715 WO2020084182A1 (es) 2018-10-25 2019-10-22 Parches transdérmicos para uso en auriculoterapia

Publications (1)

Publication Number Publication Date
MX2021002572A true MX2021002572A (es) 2021-05-12

Family

ID=64650335

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021002572A MX2021002572A (es) 2018-10-25 2019-10-22 Parches transdermicos para uso en auriculoterapia.

Country Status (5)

Country Link
US (1) US20220047526A1 (es)
EP (2) EP3643296A1 (es)
CN (1) CN112839631A (es)
MX (1) MX2021002572A (es)
WO (1) WO2020084182A1 (es)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767401A (en) * 1975-04-22 1988-08-30 Maurice Seiderman Iontophoretic administration of ionizable or polar medicaments to a mammalian body
AU4321297A (en) * 1996-10-04 1998-04-24 Saitama Daiichi Seiyaku Kabushiki Kaisha Patch
US7232830B2 (en) * 1998-06-26 2007-06-19 Elaine A Delack Method for treatment of neurodegenerative diseases and effects of aging
CN1341436A (zh) * 2001-09-30 2002-03-27 曲强 一种治疗耳聋、耳鸣的外用中药贴剂
US6730667B2 (en) * 2001-11-26 2004-05-04 William R. Deagle Iontophoresis disc pain blocker
US8252321B2 (en) * 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
GB2438926A (en) * 2006-06-07 2007-12-12 Paul Marshall Transdermal patch
US20100105634A1 (en) * 2007-03-07 2010-04-29 Cargill, Incorporated Use of glucosamine as a mental and physical stress recovery enhancer and a performance enhancer
CN103458909A (zh) * 2010-12-29 2013-12-18 战略科学与技术有限责任公司 治疗偏头痛和其它适应症的方法和系统
CA2863880A1 (en) * 2013-09-24 2015-03-24 Platinum Naturals Ltd. Eucommia ulmoides-containing chocolate compositions
US20180243251A1 (en) * 2017-02-24 2018-08-30 Ioffe Biotechnologies Inc. Composition and Method for Improving Cognitive Function
CN108635555B (zh) * 2018-06-25 2021-04-06 深圳市宝安中医院（集团） 一种治疗抑郁障碍的中药穴位贴膏剂及其制备方法

Also Published As

Publication number Publication date
EP3643296A1 (en) 2020-04-29
WO2020084182A1 (es) 2020-04-30
US20220047526A1 (en) 2022-02-17
EP3871659A1 (en) 2021-09-01
CN112839631A (zh) 2021-05-25

Similar Documents

Publication Publication Date Title
IL287604A (en) Formulations of pthrp analogs, their transdermal dressings and their uses
MX2019011431A (es) Inhibidores de proteina 1 de muerte celular programada (pd-1)/ligando 1 de muerte programada (pd-l1).
IL269644A (en) Combined treatments targeting PD-1, TIM-3 and LAG-3
MX2018008190A (es) Sistemas y metodos para la administracion transdermica a largo plazo.
PH12019502291A1 (en) Anticancer combination therapy
PH12019501097A1 (en) Magl inhibitors
CR20190537A (es) Inhibidores pirazólicos de magl
MX2023006706A (es) Administracion transdermica de agentes grandes en composiciones de emulsion mediante acondicionamiento de la piel con microagujas y sus usos.
PH12019501102A1 (en) Magl inhibitors
EP3481414A4 (en) FORMULATIONS OF ABALOARATIDE, TRANSDERMAL PLASTERS THEREOF AND USES THEREOF
NZ741566A (en) Modulators of sestrin-gator2 interaction and uses thereof
MX2017003623A (es) Parche de opipramol.
MX2019015676A (es) Uso de isovaleril espiramicina i, ii y/o iii en la fabricación de medicamentos para el tratamiento y/o la prevención de tumores, y el medicamento.
MX2016005669A (es) Revestimiento de alginato para tratamiento de tallos.
MX2018003301A (es) Inhibidores de pcna.
MX2021006102A (es) Suministro mejorado de agentes grandes.
MX2019008338A (es) Composicion farmaceutica que contiene sulglicotido o una sal farmaceuticamente aceptable del mismo para la prevencion o tratamiento del ojo seco.
PH12016501733A1 (en) Pharmaceutical composition for preventing or treating skin rash
EP3479827A4 (en) INJECTABLE COMPOSITION FOR TOPIC REDUCTION OF PAIN FREE FAT, EDEMA AND SIDE EFFECTS, AND PREPARATION METHOD THEREOF
PH12019502145A1 (en) Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient
MX2021002572A (es) Parches transdermicos para uso en auriculoterapia.
EP3727397A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT, RELIEF OR PREVENT NEUROPATHIC PAIN, CONTAINING GLYCERYLPHOSPHORYLCHOLINE AS ACTIVE INGREDIENT
EP3723766A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT, MITIGATION OR PREVENTION OF MUSCLE CRAMPS, CONTAINING CHOLINE ALFOSCERATE AS ACTIVE INGREDIENT
EP3586833A4 (en) TRANSDERMAL PATCH BASE AND TRANSDERMAL PATCH USING THE SAME
GB201915627D0 (en) Transdermal patch